Risk factors
TherapeuticsMD (TXMD) risk factors
Item 1A of every TherapeuticsMD, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors51 risks3 new2 dropped10 reworded
Legal disputes with licensee Mayne Pharma escalate into active lawsuits over rebates, returns, and working capital.
Filed Mar 30, 2026 - FY2024 10-K risk factors50 risks
The company operates strictly as a royalty-dependent business following the Mayne Transaction, relying on third-party licensees for product sales.
Filed Mar 27, 2025